Drug Profile
GDF 1
Alternative Names: Growth/differentiation factor 1Latest Information Update: 27 Oct 2004
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Developer CeNeS Pharmaceuticals; Curis; Nonindustrial source
- Class Growth factors
- Mechanism of Action Intercellular signalling peptide and protein stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Multiple sclerosis
Most Recent Events
- 27 Oct 2004 Discontinued - Preclinical for Multiple sclerosis in USA (unspecified route)
- 22 Jun 2001 No-Development-Reported for Multiple sclerosis in USA (Unknown route)
- 16 Feb 2001 Cambridge NeuroScience is now called CeNeS Pharmaceuticals